Live from the NIH registry
Studies recruiting near Tucson right now
Top 25 of 472 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: SWOG Cancer Research Network
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Lupus Research Alliance
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: National Cancer Institute (NCI)
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Cystic Fibrosis, CFTR Gene Mutation
Phase 2
Interventional 33 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Arcturus Therapeutics, Inc.
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Tucson, Arizona (5.4 mi)
· Sponsor: Sameek Roychowdhury
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Heart Failure
Phase 2
Interventional 200 participants sought
TMC Hlthcr Clin Res Office — Tucson, Arizona (5.4 mi)
· Sponsor: Novo Nordisk A/S
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
The University of Arizona Cancer Center - North Campus — Tucson, Arizona (5.4 mi)
· Sponsor: Eli Lilly and Company
Wellness Intervention for Smoking and HIV
HIV, Sleep
N/A
Interventional 200 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep
Insomnia, Primary
N/A
Interventional 20 participants sought
University of Arizona Psychiatry Department — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Advanced Cancer
Phase 1
Interventional 164 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Riboscience, LLC.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: National Cancer Institute (NCI)
Establishing Normative Urodynamics Parameters for the Glean Urodynamics System in Healthy Adults
Lower Urinary Tract Symptoms (LUTS)
N/A
Interventional 72 participants sought
Del Sol Research Management — Tucson, Arizona (5.4 mi)
· Sponsor: Bright Uro
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
Liver Fibrosis, Hepatic Cirrhosis
Phase 2
Interventional 104 participants sought
Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: AstraZeneca
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Prediabetic State, Atherosclerosis
Phase 4
Interventional 7,410 participants sought
Southern Arizona VA Health Care System, Tucson, AZ — Tucson, Arizona (5.4 mi)
· Sponsor: VA Office of Research and Development
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Alabama at Birmingham
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: AstraZeneca
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Tucson Cystic Fibrosis Center — Tucson, Arizona (5.4 mi)
· Sponsor: Nicole Hamblett
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Solid Tumor
Phase 1, Phase 2
Interventional 156 participants sought
SCRI - Arizona Oncology Associates — Tucson, Arizona (5.4 mi)
· Sponsor: Corbus Pharmaceuticals Inc.
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site - 7067 — Tucson, Arizona (5.4 mi)
· Sponsor: Galderma R&D
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Del Sol Research Management - Tucson East — Tucson, Arizona (5.4 mi)
· Sponsor: Crystalys Therapeutics
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction
N/A
Interventional 750 participants sought
Banner - University Medical Center Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: Pulnovo Medical, Inc.
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
University of Arizona Cancer Center-Orange Grove Campus — Tucson, Arizona (5.4 mi)
· Sponsor: SWOG Cancer Research Network
Enhancing Language Function in Aphasia
Aphasia, Acquired, Language Disorders
N/A
Interventional 30 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Hemorrhagic Shock, Trauma Injury
Phase 3
Interventional 1,000 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Philip Spinella
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: AstraZeneca